This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
The Precision Medicine Initiative (PMI) has been met with tremendous enthusiasm from the personalized medicine community, but it is not yet clear how practicing doctors can prepare for its implementation. That question is among the topics that will be addressed at the 11th Annual Personalized Medicine Conference.
American Medical Association (AMA) CEO & Executive Vice President James L. Madara, M.D., is among those who will discuss ways to improve genomics implementation in preparation for personalized medicine's second decade during the conference. A recent guest column published on PMC's blog by AMA Director of Personalized Medicine Katherine Johansen Taber, Ph.D., previews the Association's deep thinking on the topic.
"As the PMI begins, initiatives are urgently needed to create genomics resources and tools that are integrated into clinical practice, enabling non-geneticist physicians to become proficient in practicing precision medicine," she writes. "As newer generations of physicians are trained, they too need enhanced skills for practicing precision medicine."
Madara will discuss genomics implementation alongside experts from Memorial Sloan Kettering Cancer Center and Baystate Health at 3:15 p.m. ET on the first day of the conference, which will take place from November 18 - 19 at the Harvard School of Medicine. The event kicks off with PMC’s cocktail reception at the Hotel Commonwealth on November 17.
